Dymanthine

Dymanthine

SCHEMBL5881103

CCCCCCCCC=CCCCCCCCC(=O)O.CCCCCCCCCCCCCCCCCCN(C)C

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 4/20 0.77
▸ PPARG P37231 4/20 0.77
▸ PPARD Q03181 4/20 0.77
▸ PPARA Q07869 4/20 0.77
▸ F7 P08709 4/20 0.77
▸ F3 P13726 4/20 0.77
▸ TERT O14746 3/20 0.77
▸ PTPN1 P18031 3/20 0.77
▸ HSD17B10 Q99714 3/20 0.77
▸ FABP4 P15090 3/20 0.77
▸ MAPT P10636 2/20 0.77
▸ BLM P54132 2/20 0.77
▸ LMNA P02545 2/20 0.77
▸ ALOX15 P16050 2/20 0.77
▸ DUSP3 P51452 2/20 0.77
▸ CYP19A1 P11511 2/20 0.77
▸ PTGS1 P23219 2/20 0.77
▸ NR4A2 P43354 2/20 0.77
▸ SIRT6 Q8N6T7 2/20 0.77
▸ PTPN7 P35236 2/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Stearic Acid SCHEMBL5194349 1.00 EPHX2 (0.77) EPHX2PPARGPPARDPPARAF7
Oleic Acid SCHEMBL6156890 1.00 EPHX2 (0.77) EPHX2PPARGPPARDPPARAF7
Stearic Acid SCHEMBL5194333 1.00 EPHX2 (0.77) EPHX2PPARGPPARDPPARAF7
Oleic Acid SCHEMBL10942141 1.00 EPHX2 (0.77) EPHX2PPARGPPARDPPARAF7
Oleic Acid SCHEMBL10388079 1.00 EPHX2 (0.77) EPHX2PPARGPPARDPPARAF7
Oleic Acid SCHEMBL6156883 1.00 EPHX2 (0.77) EPHX2PPARGPPARDPPARAF7
Oleic Acid SCHEMBL10942132 1.00 EPHX2 (0.77) EPHX2PPARGPPARDPPARAF7
Dymanthine SCHEMBL5881102 1.00 EPHX2 (0.77) EPHX2PPARGPPARDPPARAF7
Oleic Acid SCHEMBL10388080 1.00 EPHX2 (0.77) EPHX2PPARGPPARDPPARAF7
Stearic Acid SCHEMBL6898448 0.95 PPARG (0.79) EPHX2PPARGPPARDPPARAF7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4548810-A AMINE SALTS FLEET BANK, NATIONAL ASSOCIATION 1985-10-22 — — US claimed
US-12606779-B2 Active agent-containing articles THE PROCTER & GAMBLE COMPANY (US) 2026-04-21 — — US disclosed
EP-4380537-A1 WATER INSOLUBLE FIBROUS ARTICLES COMPRISING ACTIVE AGENTS The Procter & Gamble Company (US) 2024-06-12 — — EP disclosed
US-11845911-B2 Active agent-containing fibrous structure articles THE PROCTER & GAMBLE COMPANY (US) 2023-12-19 — — US disclosed
US-20230399595-A1 Active Agent-Containing Articles PROCTER & GAMBLE (US) 2023-12-14 — — US disclosed
US-11781095-B2 Active agent-containing articles THE PROCTER & GAMBLE COMPANY (US) 2023-10-10 — — US disclosed
US-20230092174-A1 ACTIVE AGENT-CONTAINING ARTICLES PROCTER & GAMBLE (US) 2023-03-23 — — US disclosed
WO-2023014694-A1 WATER INSOLUBLE FIBROUS ARTICLES COMPRISING ACTIVE AGENTS THE PROCTER & GAMBLE COMPANY (US) 2023-02-09 — — WO disclosed
US-20210301230-A1 Active Agent-Containing Fibrous Structure Articles THE PROCTER & GAMBLE COMPANY 2021-09-30 — — US disclosed
US-20210239104-A1 Active Agent-Containing Articles THE PROCTER & GAMBLE COMPANY 2021-08-05 — — US disclosed
WO-1997016516-A1 STABLE HIGH PERFUME, LOW ACTIVE FABRIC SOFTENER COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-05-09 — — WO disclosed
WO-1997003173-A1 DRYER-ACTIVATED FABRIC CONDITIONING AND ANTISTATIC COMPOSITIONS WITH IMPROVED PERFUME LONGEVITY THE PROCTER & GAMBLE COMPANY (US) 1997-01-30 — — WO disclosed
US-5562847-A QUATERNARY AMMONIUM SOFTENING COMPOUND AND THE ESTER OF A PERFUME ALCOHOL THE PROCTER & GAMBLE COMPANY (US) 1996-10-08 — — US disclosed
EP-0712435-A1 DRYER-ACTIVATED FABRIC CONDITIONING AND ANTISTATIC COMPOSITIONS CONTAINING BIODEGRADABLE COMPOUNDS HAVING UNSATURATION THE PROCTER & GAMBLE COMPANY (US) 1996-05-22 — — EP disclosed
US-5510042-A LOW-SUDSING, LOW LATHERING THE PROCTER & GAMBLE COMPANY (US) 1996-04-23 — — US disclosed
US-5500137-A Fabric softening bar compositions containing fabric softener and enduring perfume THE PROCTER & GAMBLE COMPANY (US) 1996-03-19 — — US disclosed
WO-1996001889-A1 FABRIC SOFTENING BAR COMPOSITIONS CONTAINING FABRIC SOFTENER, NONIONIC PHASE MODIFIER AND WATER THE PROCTER & GAMBLE COMPANY (US) 1996-01-25 — — WO disclosed
US-5476599-A Containing a quaternary ammonium compound and a tertiary amine salt of a carboxylic acid THE PROCTER & GAMBLE COMPANY (US) 1995-12-19 — — US disclosed
WO-1995004802-A1 DRYER-ACTIVATED FABRIC CONDITIONING AND ANTISTATIC COMPOSITIONS CONTAINING BIODEGRADABLE COMPOUNDS HAVING UNSATURATION THE PROCTER & GAMBLE COMPANY (US) 1995-02-16 — — WO disclosed
US-4548810-A AMINE SALTS FLEET BANK, NATIONAL ASSOCIATION 1985-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210301230-A1 Active Agent-Containing Fibrous Structure Articles MMP1, FIBP, MMP8 EPHX2 1516/4885PPARG 3643/4885PPARD 4222/4885
US-11781095-B2 Active agent-containing articles POLR1C, MPO, MMP8 EPHX2 1073/4885PPARG 2801/4885PPARD 3969/4885
US-20230399595-A1 Active Agent-Containing Articles POLR1C, MPO, MMP8 EPHX2 1073/4885PPARG 2801/4885PPARD 3969/4885
US-20230092174-A1 ACTIVE AGENT-CONTAINING ARTICLES MFAP1, PCLAF, CD68 EPHX2 1381/4885PPARG 927/4885PPARD 1322/4885
US-12606779-B2 Active agent-containing articles ASH2L, CD69, WASHC5 EPHX2 741/4885PPARG 4512/4885PPARD 4872/4885
US-11845911-B2 Active agent-containing fibrous structure articles MMP1, FIBP, MMP8 EPHX2 1516/4885PPARG 3643/4885PPARD 4222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback